EarningsQ2 2026 Earnings Report
MX:MFCN Q2 2026 EPS Results
Actual EPS$13.35
Consensus EPS$13.23
Beat/MissBeat by +$0.12
One Year Ago EPS$11.64
MX:MFCN Q2 2026 Revenue Results
Actual Revenue$244.94B
Expected Revenue―
Beat/Miss―
YoY Revenue Growth+28.19%
Earnings Announcement Details
QuarterQ2 2026
Date08/05/2026
TimeAfter Close
Conference CallWednesday, August 5, 2026
MX:MFCN Upcoming Earnings
Manulife Financial's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
MX:MFCN Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call highlighted multiple strong operating and financial results — double-digit APE growth across segments, meaningful improvements in new business metrics and core EPS, robust capital ratios (LICAT 136%) and strategic execution including an innovative LTC biometric risk transfer and AI leadership. Headwinds include unfavorable insurance experience in Canada and some U.S. life spread/ALDA pressure, targeted outflows in parts of Global WAM, and elevated central expenses. Management presented these challenges as manageable with mitigating actions (claims management, repricing ability, continued capital generation and targeted investments). Overall, the positives around growth, profitability, capital strength and risk-reduction transactions materially outweigh the contained negatives.Company Guidance
Strong APE Sales Growth Across Segments
Total APE sales grew 21% year-over-year with double-digit growth across all insurance segments: Asia +21%, Canada +23%, U.S. +12%. APE sales per active agent increased over 30% YoY.
Improved New Business Economics and CSM
New business CSM increased 16% YoY and overall CSM balance grew 20%, supporting future earnings generation and demonstrating improvement in value metrics.
Profitability and EPS Growth
Core EPS grew 16% YoY, driven by 12% growth in core earnings and share buybacks; adjusted book value per share rose 15% YoY to $41.12.
Asia and Global WAM Outperformance
Asia core earnings increased 21% YoY to a record level; Global WAM generated 10% pretax earnings growth, returned to net inflows of $0.4 billion supported by record gross flows, and expanded core EBITDA margin to 31.2% (up 110 bps YoY).
Capital and Balance Sheet Strength
LICAT ratio of 136% (about $26 billion in excess of supervisory target) and financial leverage at 22.2% (below 25% medium-term target) provided flexibility; returned $5.3 billion of capital to shareholders over the past 12 months and $1.4 billion in the quarter.
Long-Term Care (LTC) Risk Reduction Transaction
Completed a biometric risk-only LTC reinsurance with Munich Re: full transfer of biometric risk on $3.2 billion of reserves at an 80% quota share, reducing LTC morbidity risk by 24% (inclusive of prior transactions); transaction priced with a modest ~5% negative ceding commission (IFRS) and ~6–7% on NAIC basis; foregone core earnings ~CAD 30 million in year one.
Operational and Innovation Achievements
Recognized as #1 life insurer for AI maturity (Evident) and Model Insurer for Data, Analytics & AI (Celent); launched enterprise AI platform and Agentic AI solutions; expanded product offerings (high net worth insurance solutions, ETF offerings, VUL enhancements) and scaled agency training and capability programs (Manulife Business Academy).
MX:MFCN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed